Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Heidegger

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Pathophysiology : the Official Journal of the International Society for Pathophysiology|October 24, 2025
MicroRNA-371a-3p Represents a Novel and Effective Diagnostic Marker for Testicular Germ Cell Tumours: A Real-World Prospective Comparison with Conventional ApproachesMargherita Palermo, Carolina D'Elia, Giovanni Mazzucato, et al.
Oncogene|April 2, 2021
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancerMartin Puhr, Andrea Eigentler, Florian Handle, et al.
Cancers|February 16, 2020
The Impact of Cand1 in Prostate CancerAndrea Eigentler, Piotr Tymoszuk, Johanna Zwick, et al.
Journal of Medicinal Chemistry|December 18, 2024
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan DerivativesAnna M Schoepf, Maximilian Gebhart, Martin Federspiel, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2024
An NMR-Based Metabolic Signature to Identify Clinically Significant Prostate Cancer in Patients Undergoing BiopsyMichael Ladurner, Tobias Ameismeier, Helmut Klocker, et al.
Oncotarget|March 10, 2016
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapiesAndreas Pircher, Karin Jöhrer, Florian Kocher, et al.
Frontiers in Cell and Developmental Biology|December 11, 2025
Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlatesElisabeth Damisch, Elena Brunner, Lukas Nommensen, et al.
Urologic Oncology|October 1, 2018
Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary updateIgor Tsaur, Isabel Heidegger, Alexander Kretschmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2024
Efficacy and safety of rechallenge with [<sup>177</sup>Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancerGiulia Santo, Gianpaolo Di Santo, Anna Sviridenko, et al.
World Journal of Urology|March 20, 2015
Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blotRenate Pichler, Wegene Borena, Georg Schäfer, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Pathophysiology : the Official Journal of the International Society for Pathophysiology|October 24, 2025
MicroRNA-371a-3p Represents a Novel and Effective Diagnostic Marker for Testicular Germ Cell Tumours: A Real-World Prospective Comparison with Conventional ApproachesMargherita Palermo, Carolina D'Elia, Giovanni Mazzucato, et al.
Oncogene|April 2, 2021
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancerMartin Puhr, Andrea Eigentler, Florian Handle, et al.
Cancers|February 16, 2020
The Impact of Cand1 in Prostate CancerAndrea Eigentler, Piotr Tymoszuk, Johanna Zwick, et al.
Journal of Medicinal Chemistry|December 18, 2024
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan DerivativesAnna M Schoepf, Maximilian Gebhart, Martin Federspiel, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2024
An NMR-Based Metabolic Signature to Identify Clinically Significant Prostate Cancer in Patients Undergoing BiopsyMichael Ladurner, Tobias Ameismeier, Helmut Klocker, et al.
Oncotarget|March 10, 2016
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapiesAndreas Pircher, Karin Jöhrer, Florian Kocher, et al.
Frontiers in Cell and Developmental Biology|December 11, 2025
Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlatesElisabeth Damisch, Elena Brunner, Lukas Nommensen, et al.
Urologic Oncology|October 1, 2018
Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary updateIgor Tsaur, Isabel Heidegger, Alexander Kretschmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2024
Efficacy and safety of rechallenge with [<sup>177</sup>Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancerGiulia Santo, Gianpaolo Di Santo, Anna Sviridenko, et al.
World Journal of Urology|March 20, 2015
Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blotRenate Pichler, Wegene Borena, Georg Schäfer, et al.
Pageof 16